Clinical value of squamous cell carcinoma antigen (SCC-A) in Egyptian gynecologic cancer patients

Anticancer Research

Volumn 17, Issue 4 B, 1997, Pages 3083-3086

  Salman, Tarek ^a   El Ahmady, Omar ^a,c   Tony, Osama ^b   Darwish, Mostafa ^a  

^a AL AZHAR UNIVERSITY   (Egypt)

^b MILITARY MEDICAL ACADEMY   (Egypt)

^c Al Azhar University   (Egypt)

Author keywords

Benign and malignant gynecologic diseases; Serum SCC A

Indexed keywords

SQUAMOUS CELL CARCINOMA ANTIGEN;

ADULT; BLOOD LEVEL; CANCER STAGING; CLINICAL TRIAL; CONFERENCE PAPER; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CYSTADENOCARCINOMA; ENDOMETRIUM CANCER; FEMALE; GYNECOLOGIC CANCER; HIGH RISK POPULATION; HISTOPATHOLOGY; HUMAN; MAJOR CLINICAL STUDY; OVARY CANCER; PRIORITY JOURNAL; SQUAMOUS CELL CARCINOMA; UTERINE CERVIX CANCER; VAGINA CANCER; VULVA CARCINOMA;

ADOLESCENT; ADULT; AGED; ANTIGENS, NEOPLASM; FEMALE; GENITAL NEOPLASMS, FEMALE; HUMANS; MIDDLE AGED; NEOPLASM STAGING; SENSITIVITY AND SPECIFICITY; SERPINS; TUMOR MARKERS, BIOLOGICAL;

EID: 0030750983     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (41)

1. Battaglia F, Scambia G, Panici PB, Castelli M, Ferrandina G, Foti E, Amorosi M, D'Andrea G and Mancusos S: Immunosuppressive acidic protein (IAP) and Squamous cell carcinoma antigen (SCC-A) in patients with cervical cancer. Gynecol Oncol 53(2): 176, 1994.
2. Beastall GH, Cook B, Rustn GJS and Jenniggs J: A review of the role of established tumor markers. Ann Clin Biochem 28: 5, 1991.
3. Borras G, Molina R, Xerocavins J and Ballesta A: Squamous cell carcinoma antigen in cervical cancer. Eur J Gynecol Oncol 19: 118, 1992.
4. Collazos J and Rodriguez J: Squamous cell carcinoma antigen in patients with cirrhosis. Clin Chem 39(3): 548, 1993.
5. Crombach G and Wurz H: Carcinoma of the female genital tract. In: Lüthgens M, Schlegel G, eds. Clinical use of tumor marker system CEA-TPA. Tumor Diagnostik Verlag, Leonberg, 51, 1989.
6. Crombach G, Scharl A, Verbuchan M, Wurz H and Bolte A: Detection of SCC-A in normal squamous epithelia and in SCC of uterine cervix. Cancer 63: 1337, 1989.
7. Daunter B: Tumor markers in gynecologic oncology. Gyn Oncol 39: 1, 1990.
8. Duk JM, Ten-Hoor HK, Hollema H, Doeglas HM and De Bruijn HW: Elevated levels of SSC-A in patients with benign diseases of skin. Cancer 64(8): 1652, 1989.
9. Ebert W, Dienemann H, Fateh-Moghadam A, Scheulen M, Konietzko N, Schleich T, and Bombardieri E: Cytokeratin 19 fragment CYFRA 21 compared with carcinoembryonic antigen, Squamous cell carcinoma antigen and neuron-specific enolase in lung cancer. Eur J Clin Chem Clin Biochem 32(3): 189, 1994.
10. El-Ahmady O, Barakat M, El-Ghazawy I and Afify M: The clinical value of SCC-A in bladder cancer. Egypt J Tumor Marker Oncol 2(1): 79, 1991.
11. El-Ahmady O, Halim AB, Hamza S, Aboul-Ela M and Oehr P: Urinary SCC-A in Egyptian bladder cancer patients. Egypt J Tumor Marker Oncol 3(2): 35, 1992.
12. Ferdeghini M, Gadducci A, Annicchiarico C, Prontera C, Malagnino G, Castellani C, Facchini V and Bianchi R: Serum CYFRA 21-1 assay in squamous cell carcinoma of the cervix. Anticancer Res 13(5C): 1841, 1993.
13. Fontana X, Lagrange JL, Francois E, Bourry J, Chauvel P, Sordage M, Lapalus F and Namer M: Assessment of squamous cell carcinoma antigen as a marker of epidermoid carcinoma of the anal canal. Dis Colon Rectum 34(2): 126, 1991.
14. Gadducci A, Ferdeghini M, Prontera C, Giordano P, Cristofani R, Bianchi R and Fioretti P: A comparison of pretreatment serum levels of four tumor markers in patients with endometrial and cervical carcinoma. Eur J Gynaecol Oncol 11(4): 283, 1990.
15. Ghosh BC and Rob CG: Tumor markers. In: Ghosh BC, Ghosh Leds. Tumor markers and tumor associated antigens New York, London, McGraw-Hill, 1, 1987.
16. Goldman S, Svensson C, Bronnergard M, Glimelius B and Wallin G: Prognostic significance of serum concentration of SCC-A in anal epidermoid carcinoma. Int J Colon-rectal Dis 8(2): 98, 1993.
17. Hsieh CY, Chang DY, Huang SC, Yen ML, Junag GT and Ouyong PC: Serum SCC-A in gynecologic malignancies with reference to cervical cancer. Taiwan Haueh Hui Tsa Chih 88(8): 797, 1989.
18. Kato H and Torigoe T: Radioimmunoassay for tumor antigen of human cervical SCC. Cancer 41: 1621, 1977.
19. Kato H, Morioka H, Aramaki S, Tamaki S and Torigoe T: Prognostic significance of TA-4 in SCC of the uterine cervix. Am J Obstet Gynecol 145: 128, 1983.
20. Kurokawa H, Tsuru S, Okada M, Nakamura T and Kajiyama M: Evaluation of tumor markers in patients with squamous cell carcinoma in the oral cavity. Int J Oral Maxillofac Surg 22(1): 35, 1993.
21. Lam CP, Yuan CC, Jeng FS, Tsai LC, Yeh SH and Ng HT: Evaluation of CEA, TPA and SCC-A in the detection of cervical cancer. Chung Hua I Hsueh Tsa Chih Taipei 50(1): 7, 1992.
22. Maruo T, Shibata K, Kimura A, Hoshina M and Mochizuki M: TA-4 in the monitoring of therapy for SCC of the uterine cervix. Cancer 56(2): 302, 1990.
23. Mastuda H, Mori M, Tsujitani O, Kuwano H and Sugimachi K: Immunohistochemical evaluation of SCC-A and S-100 protein positive cells in human malignant oesophageal tissues. Cancer 65: 2261, 1990.
24. Matorras R, Rodriguez-Escuderoi Fj, Diez J, Genolla J, Cruz-Fombellida J and Ruibal A: Monitoring endometrial adenocarcinoma with a four tumor marker combination. Acta Obstet Gynecol Scand 71(6): 458, 1992.
25. Miyazaki K, Tokunaga T, Katabuchi H, Ohba T, Tashiro H and Okamura H: Clinical usefulness of serum SCC-A for early detection of squamous cell carcinoma arising in mature cystic teratoma of the ovary. Obstet Gynecol 78(3 pt 2): 562, 1991.
26. Mokhtar N: Female genital system tumors. In: Cancer pathology registry 1985-1990, National Cancer Institute, Cairo University, 45, 1991.
27. Molina R, Fillela X, Torres MD, Ballesto AM, Mengual P, Cases A and Balaque A: SCC-A measured in malignant and non malignant diseases. Clin Chem 36(2): 251, 1990.
28. Nikliniski J, Furman M, Laudanski J and Kozlowski M: Prognostic value of pretreatment CEA, SCC-A and CA 19-9 levels in patients with NSCLC. Eur J Cancer Prev 1(6): 401, 1992.
29. Numahara T, Nakashima K, Yamamoto S and Nishimoto M: Significance of squamous cell carcinoma-related antigen in psoriasis and generalized eczema. Preliminary report. Dermatologica 178(2): 73, 1989.
30. Pectasides D, Bourazanis J, Economides N, Pozadzidou P, Gogou L, Koutsiouba P and Athanassiou A: SCC-A, CEA and TATI for monitoring head and neck cancer. Int J Biol Markers 8(2): 81, 1993.
31. Picerdo AL-Torres AJ, Maestro M, Ortega D, Garcia-Asenjo JA, Mugerza JM, Herando I, Diez M and Balibrea JL: Quantitative analysis of CEA, SCC-A, CA 125 and CA 50 cytosolic content in non-small cell lung cancer. Cancer 73(9): 2305, 1994.
32. Petrelli NJ, Palmer M, Herrera L and Bhargava A: The utility of squamous cell carcinoma antigen for the follow-up of patients with squamous cell carcinoma of the anal canal. Cancer 70(1): 35, 1992.
33. Sanchez J, Masa F, Dela-Cruz JL, Disdier C and Vegara C: Squamous cell carcinoma antigen (SCC-A) in the diagnosis and prognosis of lung cancer. Chest 105(3): 773, 1994.
34. Screm MC, Grandis S, Cortei G and Cottaruzzi E: Detection of five circulating antigens in patients with head and neck SCC. Int J Biol Markers, 4(1): 35, 1989.
35. Shirato H, Ichimura W, Wakushima H, Nishioka T and Suzuki K: Squamous cell carcinoma antigen in serum for monitoring of head and neck and uterine cervical Squamous cell carcinoma after radiotherapy. Acta Oncol 32(6): 663,1993.
36. Takeshima N, Nakamura K, Takeda O, Morioka H, Tamura H, Takasugi N and Kato H: Individualization of the cutoff value for serum squamous cell carcinoma antigen using a sensitive enzyme immunoassay. Tumor Biol 11(3): 167, 1990.
37. Tsukahara T, Otoyama K and Horiuchi Y: Significance of elevated Squamous cell carcinoma (SCC)-related antigen and lactate dehydrogenase (LDH) levels in senile erythroderma following eczema. J Dermatol 20(6): 346, 1993.
38. Ueda G, Inoue Y and Yamasaki M: Immunohistochemical demonstration of TA-4 in gynecologic tumors. Int J Gynecol Pathol 3: 291, 1984.
39. Walther EK, Dahlmann N and Gorgulla HT: Tumor markers in the diagnosis and follow-up of head and neck cancer,role of CEA, CA 19-9,SCC-A, TK and dTTPase. Head Neck 15(3): 230, 1993.
40. Yamazaki K, Kumamoto Y and Tsukamoto T: Expression of squamous cell carcinoma-associated antigen in grade 3 pT1 transitional cell carcinoma of the bladder and prediction of its progression and intravesical recurrence. Cancer 72(12): 3676, 1993.
41. Yamazaki K, Kumamoto Y and Tsukamoto T: Expression of squamous cell carcinoma-associated antigen in bladder cancer cells. A comparative study with the expression of proliferating cell nuclear antigen(PCNA). Nippon Hinyokika Gakkai Zasshia 85(4): 589, 1994.